Mark Mallon BSE, MBA

Mark Mallon is a member of AstraZeneca’s senior executive team and leads the strategic functions, Global Product & Portfolio Strategy (GPPS), Global Medical Affairs (GMA), and Corporate Affairs (CA). These functions integrate corporate, therapy area and product strategies to act as a bridge between scientific development and commercial excellence.

Mark is also the senior sponsor for AstraZeneca’s Healthy Heart Africa initiative, which aims to reach 10 million hypertensive patients across Africa in the next ten years.